CIK 0000874501
- Accelerated filer
OCTAVE SPECIALTY GROUP INC
Sign in to watch- Ticker
- OSG
- Exchange
- NYSE
- Industry
- Surety Insurance
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 133621676
- Phone
- +1 212-658-7470
- Business address
- 40 WALL STREET, 55TH FLOOR, NEW YORK, NY, 10005
- Former names
- AMBAC FINANCIAL GROUP INC, AMBAC INC /DE/
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-28 | LeBlanc Claude Chief Executive Officer | Option exercise · Restricted Stock Units | −24,780 | 127,666 | ||
| 2024-02-28 | LeBlanc Claude Chief Executive Officer | Grant or award · Deferred Share Units | +24,780 | 286,668 | ||
| 2024-02-28 | Trick David Exec VP, CFO & Treasurer | Option exercise | +220 | 152,602 | ||
| 2024-02-28 | Trick David Exec VP, CFO & Treasurer | Shares withheld for taxes | −220 | $16.94 | $4K | 152,382 |
| 2024-02-28 | Trick David Exec VP, CFO & Treasurer | Option exercise · Restricted Stock Units | −220 | 30,873 | ||
| 2024-02-28 | Smith R Sharon Exec VP & Chief Strategy Offr | Option exercise | +196 | 73,803 | ||
| 2024-02-28 | Smith R Sharon Exec VP & Chief Strategy Offr | Shares withheld for taxes | −196 | $16.94 | $3K | 73,607 |
| 2024-02-28 | Smith R Sharon Exec VP & Chief Strategy Offr | Option exercise · Restricted Stock Units | −196 | 32,688 | ||
| 2024-02-28 | Smith R Sharon Exec VP & Chief Strategy Offr | Option exercise · Restricted Stock Units | −5,359 | 27,329 | ||
| 2024-02-28 | Smith R Sharon Exec VP & Chief Strategy Offr | Grant or award · Deferred Share Units | +5,359 | 60,084 | ||
| 2024-02-28 | Ksenak Stephen Michael Sr. MD & General Counsel | Option exercise | +178 | 111,787 | ||
| 2024-02-28 | Ksenak Stephen Michael Sr. MD & General Counsel | Shares withheld for taxes | −178 | $16.94 | $3K | 111,609 |
| 2024-02-28 | Ksenak Stephen Michael Sr. MD & General Counsel | Option exercise · Restricted Stock Units | −178 | 29,903 | ||
| 2024-02-28 | Ksenak Stephen Michael Sr. MD & General Counsel | Option exercise · Restricted Stock Units | −4,872 | 25,031 | ||
| 2024-02-28 | Ksenak Stephen Michael Sr. MD & General Counsel | Grant or award · Deferred Share Units | +4,872 | 56,080 | ||
| 2024-02-28 | BARRANCO DAVID Senior Managing Director | Option exercise | +5,723 | 106,055 | ||
| 2024-02-28 | BARRANCO DAVID Senior Managing Director | Shares withheld for taxes | −2,063 | $16.94 | $35K | 103,992 |
| 2024-02-28 | BARRANCO DAVID Senior Managing Director | Option exercise · Restricted Stock Units | −5,723 | 28,370 | ||
| 2024-02-28 | Eisman Robert Bryan Sr. MD & CAO | Option exercise | +71 | 67,687 | ||
| 2024-02-28 | Eisman Robert Bryan Sr. MD & CAO | Shares withheld for taxes | −71 | $16.94 | $1K | 67,616 |
Page 20 of 24 · 466 trades